Trial Condition(s):
N/A
TOCOSOL paclitaxel and carboplatin in NSCLC
Bayer Identifier:
91532
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Terminated/Withdrawn
Trial Purpose
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
N/A
Trial Dates
N/A
Phase
2
Could I receive a placebo?
No
Products
Tocosol-Paclitaxel (BAY86-5312)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
| Locations |
|---|
Trial Design
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
Prevention
Allocation:
Randomized
Blinding:
Open Label
Assignment:
Parallel Assignment
Trial Arms:
N/A
Primary Outcome
- cycle control and bleeding patternTimeframe: 7 cycles
Secondary Outcome
- Pearl indexTimeframe: 7 cycles
- Laboratory testsTimeframe: Screening
- Adverse EventsTimeframe: 7 cycles
- General Physical and gynecological examinationsTimeframe: Screening
- Vital signsTimeframe: Screening, admission
- Body weightTimeframe: Screening, admission
Additional Information
Copyright © Bayer
Powered by
